Juvenile Idiopathic Arthritis

By M. Beresford. Paediatric drugs, 2011

2,017 citations recorded by the source corpus.

Subfields: Hematology, Speech and Hearing, Surgery

View Paper: https://www.semanticscholar.org/paper/b4d2791f40c32777d6e4b608135aca32b7977fc3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Magni-Manzoni
2. S. Viola
3. A. Consolaro
4. C. Malattia
5. G. Filocamo
6. A. Bazsó
7. A. Pistorio

Citations in the corpus

• Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. (2012, neutral): “Rash 24/41 (59) 20/43 (47) 4/43 (9) 79/177 (45) 1/100 (1) 3/50 (6) 9/50 (18)”
• Development and validation of a composite disease activity score for juvenile idiopathic arthritis. (2009, background): “Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease with a widely variable clinical course and outcome (1).”